PCR-based Enteric Disease Testing Market

PCR-based Enteric Disease Testing Market: Introduction

• Enteric illnesses are intestinal infections triggered by a number of bacteria, viruses, and parasites such as salmonella, shigella, Giardia lamblia, campylobacter, cryptosporidium, and vibrio cholerae. These enter the body through the mouth or intestinal tract and cause salmonella, shigellosis, giardiasis, campylobacteriosis, cryptosporidiosis, and cholera. Common symptoms of enteric diseases include nausea, vomiting, diarrhea, abdominal cramps, fever, chills, and loss of appetite. Enteric bacteria has been identified as one of the major causative organisms of water and foodborne diseases. Prevalence of hemolytic uremic syndrome and diarrhea (HUS) is increasing across the world. These are mostly caused by enteric bacterial infections.

PCR-based Enteric Disease Testing Market: Key Trends

• High morbidity and rapid spread of enteric bacterial infection is projected to propel the global PCR-based enteric disease testing market. Prevalence of water and foodborne diseases is rising across the globe, especially in underdeveloped and developing countries. The epidemic of E. coli infection in Germany had spread to various parts of the world (more than 10 countries), including the U.S., the U.K., Spain, and France in 2011. Various environmental as well as clinical samples are tested regularly to identify enteric bacterial infection contamination and take preventive measures, especially during epidemics, in order to stop the spread of infections. Hence, rapid increase of water and foodborne enteric bacterial infection boosts the demand for enteric disease testing across the globe.
• Rise in demand for early disease diagnosis is anticipated to boost the growth of the global PCR-based enteric disease testing market. The global burden of enteric disease infection can lead to serious health care problems and even cause deaths. Typhoid salmonellosis, one of the enteric diseases, accounts for 16 million new cases and around 600,000 deaths globally each year. Early detection is the only way to stop the spread of enteric diseases. Traditional culture methods are labor intensive and time consuming. Therefore, these are being replaced by tests able to diagnose illnesses rapidly. These include enzyme immunoassay (EIA), PCR-based tests, and dipstick based tests. Increase in demand for rapid diagnostic tests is a major factor driving the global enteric disease testing market.
• Presently, the world is struggling with the COVID-19 pandemic. COVID-19 leads to pneumonia, severe & acute respiratory disorders, multiple organ failure, and, in severe cases, death. The geriatric population is more prone to COVID-19. Due the pandemic, around 342,000 women were diagnosed with enteric diseases in 2020. The global PCR-based enteric disease testing market witnessed sluggish growth during the pandemic.
• Governments of developing countries are making significant investments to modernize health care infrastructure in their respective countries, which is likely to increase access to health care. This is expected to boost demand for PCR-based enteric disease testing. Rise in prevalence of chronic diseases, especially enteric diseases, in developing countries presents lucrative opportunities in the global PCR-based enteric disease testing market.

North America to Capture Major Share of Global PCR-based Enteric Disease Testing Market

• North America is projected to account for large share of the global PCR-based enteric disease testing market during the forecast period owing to the presence of key companies offering PCR-based enteric disease testing, technological advancements, and increase in number of health care centers. Rise in prevalence of enteric diseases among the population fuels the growth of the market in the region.
• The PCR-based enteric disease testing market in Europe is likely to grow at a rapid pace during the forecast period led by increase in research & development. The PCR-based enteric disease testing market in Asia Pacific is projected to expand at a high CAGR during the forecast period due to rise in prevalence of enteric diseases and increase in awareness. 

Key Players Operating in Global PCR-based Enteric Disease Testing Market

Leading players hold major share in their respective regions. Growth strategies adopted by leading players are likely to drive the global PCR-based enteric disease testing market.

Major players operating in the global PCR-based enteric disease testing market are:

• Bio-Rad Laboratories, Inc.
• bioMérieux SA
• Thermo Fisher Scientific Inc.
• Vela Diagnostics
• Coris BioConcept
• Meridian Life Science, Inc.
• Bio-Rad Laboratories, Inc.
• Abbott
• Trinity Biotech
• DiaSorin Molecular LLC
• Other Prominent Players

Global PCR-based Enteric Disease Testing Market: Research Scope

Global PCR-based Enteric Disease Testing Market, by Indication

• Bacterial Enteric Disease
• Viral Enteric Disease
• Others

Global PCR-based Enteric Disease Testing Market, by Product

• Analyzers/Instruments
• Kits/Panels
• Others

Global PCR-based Enteric Disease Testing Market, by End-user

• Hospitals
• Diagnostic Laboratories
• Academic & Research Institutes
• Others

Global PCR-based Enteric Disease Testing Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa